| 1 |
Naqvi SAR. 99m Tc-labeled antibiotics for infection diagnosis: Mechanism, action, and progress. Chem Biol Drug Des 2022;99:56-74. [PMID: 34265177 DOI: 10.1111/cbdd.13923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Dutta J, Naicker T, Ebenhan T, Kruger HG, Arvidsson PI, Govender T. Synthetic approaches to radiochemical probes for imaging of bacterial infections. European Journal of Medicinal Chemistry 2017;133:287-308. [DOI: 10.1016/j.ejmech.2017.03.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 3 |
Rasheed R, Naqvi SAR, Gillani SJH, Zahoor AF, Jielani A, Saeed N. 99m Tc-tazobactam, a novel infection imaging agent: Radiosynthesis, quality control, biodistribution, and infection imaging studies. J Label Compd Radiopharm 2017;60:242-9. [DOI: 10.1002/jlcr.3494] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 4 |
Ebenhan T, Wagener C, Bambarger LE, Kalinda AS, Zeevaart JR. Radiochemistry. Imaging Infections 2017. [DOI: 10.1007/978-3-319-54592-9_4] [Reference Citation Analysis]
|
| 5 |
Kniess T, Laube M, Wüst F, Pietzsch J. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection. Dalton Trans 2017;46:14435-51. [DOI: 10.1039/c7dt01735a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 6 |
Akbar MU, Ahmad MR, Shaheen A, Mushtaq S. A review on evaluation of technetium-99m labeled radiopharmaceuticals. J Radioanal Nucl Chem 2016;310:477-93. [DOI: 10.1007/s10967-016-5019-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Salahinejad M, Mirshojaei SF. Quantitative structure–activity relationship analysis to elucidate the clearance mechanisms of Tc-99m labeled quinolone antibiotics. J Radioanal Nucl Chem 2016;307:437-445. [DOI: 10.1007/s10967-015-4333-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 8 |
El-kawy OA, Abdel-razek AS, Sayed MS. Radiolabeling, biological evaluation and molecular docking of delafloxacin: a novel methicillin-resistant Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem 2016;308:1081-8. [DOI: 10.1007/s10967-015-4586-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 9 |
Mirshojaei SF. Advances in infectious foci imaging using 99mTc radiolabelled antibiotics. J Radioanal Nucl Chem 2015;304:975-88. [DOI: 10.1007/s10967-015-4003-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 10 |
Hawary DL, Motaleb MA, Farag H, Guirguis OW, Elsabee MZ. Water-soluble derivatives of chitosan as a target delivery system of 99mTc to some organs in vivo for nuclear imaging and biodistribution. J Radioanal Nucl Chem 2011;290:557-67. [DOI: 10.1007/s10967-011-1310-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 11 |
Shah SQ, Khan MR. 99mTcN–gatifloxacin dithiocarbamate complex: a novel multi-drug-resistance Streptococcus pneumoniae (MRSP) infection radiotracer. J Radioanal Nucl Chem 2011;289:903-8. [DOI: 10.1007/s10967-011-1180-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
